Disclosures for "COPAL CNS: A Delphi Developed Core Outcome Set of Patient-reported Outcomes for PALliative Care Interventions in Adults Living With Primary CNS Cancer by a Global Interdisciplinary and Patient Stakeholder Group"
-
Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Incyte. The institution of Dr. Sharma has received research support from Novocure. The institution of Dr. Sharma has received research support from Apollomics. The institution of Dr. Sharma has received research support from Curis. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
-
Dr. Leeper has nothing to disclose.
-
Ms. Manthei has nothing to disclose.
-
Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from American Academy of Neurology. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.
-
The institution of Mr. Koekkoek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. The institution of Mr. Koekkoek has received research support from ZonMw.
-
The institution of Dr. Yogendran has received research support from Incyte. The institution of Dr. Yogendran has received research support from Dana Farber . The institution of Dr. Yogendran has received research support from FALK Catalyst. Dr. Yogendran has received personal compensation in the range of $0-$499 for serving as a speaker at community conference with Parkinson Support and Wellness. Dr. Yogendran has received personal compensation in the range of $500-$4,999 for serving as a speaker at local conference with University of Cincinnati.
-
Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Gonzalez Castro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishing. Dr. Gonzalez Castro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ Best Practice. Dr. Gonzalez Castro has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. An immediate family member of Dr. Gonzalez Castro has or had stock in Takeda. The institution of Dr. Gonzalez Castro has received research support from Merck & Co.
-
The institution of Prof. Philip has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Philip has received research support from Cancer Council Victoria.